Income Statement NEXON Co., Ltd.

Equities

3659

JP3758190007

Internet Services

Market Closed - Japan Exchange Other stock markets 12:00:00 13/04/2026 pm IST			5-day change	1st Jan Change
2,640.50 ^JPY	-0.71%		-1.01%	-31.00%

01/04	Middle East War Prospects Bouy Asian Stock Markets	MT
31/03	NEXON Co., Ltd. - Analyst/Investor Day

1.YHD-02TJDy4XnZ2ptSuV8w7c1U-Y9hPAZw6HbIDTF4w.VQrGmA7-ZX9E76re-0z-pEKflCX0kyGyXnv1BLSJRLUINNOXCZlmQkT46g

Published financial data: NEXON CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	27TCr	35TCr	42TCr	45TCr	48TCr
Total Revenues	27TCr	35TCr	42TCr	45TCr	48TCr
Cost of Goods Sold, Total	7.21TCr	11TCr	14TCr	16TCr	19TCr
Gross Profit	20TCr	25TCr	29TCr	28TCr	28TCr
Selling General & Admin Expenses, Total	8.2TCr	11TCr	12TCr	11TCr	13TCr
Provision for Bad Debts	-	-	558.9Cr	5.1Cr	52Cr
R&D Expenses	2.1TCr	2.59TCr	2.46TCr	2.49TCr	2.64TCr
Depreciation & Amortization - (IS)	544.4Cr	374.7Cr	430.7Cr	453.8Cr	451.8Cr
Other Operating Expenses	-44Cr	-43Cr	-11Cr	82Cr	-4.6Cr
Other Operating Expenses, Total	11TCr	14TCr	15TCr	14TCr	16TCr
Operating Income	9.43TCr	11TCr	13TCr	14TCr	12TCr
Interest Expense, Total	-42Cr	-59Cr	-141Cr	-210.7Cr	-205.7Cr
Interest And Investment Income	645.2Cr	1.3TCr	2.46TCr	2.4TCr	2.2TCr
Net Interest Expenses	603.7Cr	1.24TCr	2.32TCr	2.19TCr	1.99TCr
Income (Loss) On Equity Invest.	-100Cr	-1.02TCr	-351Cr	-517.9Cr	-169.7Cr
Currency Exchange Gains (Loss)	3.64TCr	4.17TCr	1.04TCr	3.09TCr	-273.4Cr
Other Non Operating Income (Expenses)	-39Cr	66Cr	9.5Cr	478.3Cr	-452.2Cr
EBT, Excl. Unusual Items	14TCr	15TCr	16TCr	19TCr	13TCr
Gain (Loss) On Sale Of Investments	393.5Cr	-233.1Cr	211.6Cr	316.2Cr	959.2Cr
Gain (Loss) On Sale Of Assets	-50L	-3.2Cr	-80L	-17Cr	-2.1Cr
Asset Writedown	-382.7Cr	-1.07TCr	-3.86TCr	225.1Cr	28Cr
EBT, Incl. Unusual Items	14TCr	14TCr	13TCr	20TCr	14TCr
Income Tax Expense	2.24TCr	4.05TCr	5.48TCr	5.98TCr	5.08TCr
Earnings From Continuing Operations	11TCr	10TCr	7.11TCr	14TCr	8.97TCr
Net Income to Company	11TCr	10TCr	7.11TCr	14TCr	8.97TCr
Minority Interest	182.2Cr	35Cr	-48Cr	-136.8Cr	235.3Cr
Net Income - (IS)	11TCr	10TCr	7.06TCr	13TCr	9.21TCr
Net Income to Common Incl Extra Items	11TCr	10TCr	7.06TCr	13TCr	9.21TCr
Net Income to Common Excl. Extra Items	11TCr	10TCr	7.06TCr	13TCr	9.21TCr
Per Share Items
Net EPS - Basic	128.91	114.74	82.89	161.79	114.48
Basic EPS - Continuing Operations	128.91	114.74	82.89	161.79	114.48
Basic Weighted Average Shares Outstanding	89Cr	87Cr	85Cr	83Cr	80Cr
Net EPS - Diluted	126.55	113.81	82.33	161.09	114.11
Diluted EPS - Continuing Operations	126.55	113.81	82.33	161.09	114.11
Diluted Weighted Average Shares Outstanding	90Cr	88Cr	86Cr	84Cr	81Cr
Normalized Basic EPS	96.98	110.16	118.62	141.39	104.43
Normalized Diluted EPS	95.74	109.27	117.84	140.83	104.1
Dividend Per Share	7.5	10	10	22.5	45
Payout Ratio	3.87	8.76	12.15	7.63	26.5
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	10TCr	12TCr	14TCr	15TCr	13TCr
EBITA	9.43TCr	11TCr	13TCr	14TCr	12TCr
EBIT	9.43TCr	11TCr	13TCr	14TCr	12TCr
Effective Tax Rate - (Ratio)	16.54	28.85	43.55	30.5	36.14
Normalized Net Income	8.64TCr	9.63TCr	10TCr	12TCr	8.4TCr
Supplemental Operating Expense Items
Advertising Expense	1.74TCr	2.57TCr	3.3TCr	2.87TCr	3.62TCr
Selling and Marketing Expenses	2.31TCr	3.28TCr	4.35TCr	4.05TCr	4.61TCr
General and Administrative Expenses	283.9Cr	448.3Cr	341.5Cr	87Cr	153.4Cr
Research And Development Expense From Footnotes	2.1TCr	2.59TCr	2.46TCr	2.49TCr	2.64TCr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	37TCr	41TCr	28TCr	33TCr	50TCr
Short Term Investments	17TCr	16TCr	32TCr	27TCr	34TCr
Total Cash And Short Term Investments	53TCr	57TCr	60TCr	60TCr	84TCr
Accounts Receivable, Total	1.76TCr	3.04TCr	3.79TCr	8.87TCr	8.63TCr
Total Receivables	1.76TCr	3.04TCr	3.79TCr	8.87TCr	8.63TCr
Other Current Assets, Total	4.12TCr	3.97TCr	5.49TCr	6.27TCr	6.44TCr
Total Current Assets	59TCr	64TCr	69TCr	75TCr	99TCr
Net Property Plant And Equipment	3.54TCr	4.6TCr	5.29TCr	6.34TCr	7.97TCr
Long-term Investments	26TCr	25TCr	24TCr	33TCr	21TCr
Goodwill	3.89TCr	4.01TCr	4.39TCr	4.46TCr	4.99TCr
Other Intangibles, Total	1.77TCr	965.5Cr	1.78TCr	3.48TCr	3.67TCr
Deferred Tax Assets Long-Term	3.82TCr	5.71TCr	5.59TCr	2.86TCr	3.88TCr
Total Assets	99TCr	1,04300Cr	1,09800Cr	1,25700Cr	1,41000Cr
Liabilities
Accounts Payable, Total	935.4Cr	1.47TCr	1.63TCr	1.57TCr	4.23TCr
Accrued Expenses, Total	578.7Cr	1.02TCr	1.17TCr	2.82TCr	1.84TCr
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	304.5Cr	404.5Cr	563.4Cr	712Cr	2.08TCr
Current Income Taxes Payable	1.66TCr	2.37TCr	1.79TCr	1.91TCr	4.62TCr
Unearned Revenue Current, Total	1.1TCr	1.89TCr	2.11TCr	2.39TCr	5.54TCr
Other Current Liabilities	751Cr	1.16TCr	1.67TCr	1.37TCr	4.02TCr
Total Current Liabilities	5.33TCr	8.31TCr	8.94TCr	11TCr	22TCr
Long-Term Debt	-	-	-	-	-
Long-Term Leases	1.23TCr	1.93TCr	2.41TCr	3.29TCr	3.13TCr
Deferred Tax Liability Non Current	5.4TCr	5.04TCr	5.17TCr	5.94TCr	6.08TCr
Other Non Current Liabilities	2.12TCr	2.25TCr	2.63TCr	2.63TCr	2.88TCr
Total Liabilities	14TCr	18TCr	19TCr	23TCr	34TCr
Common Stock, Total	3.43TCr	3.9TCr	4.75TCr	5.08TCr	5.82TCr
Additional Paid In Capital	1.5TCr	1.83TCr	2.67TCr	3.01TCr	3.66TCr
Retained Earnings	71TCr	70TCr	71TCr	78TCr	87TCr
Treasury Stock	-1.79TCr	-1.65TCr	-4.5TCr	-4.92TCr	-9.38TCr
Comprehensive Income and Other	9.27TCr	11TCr	16TCr	21TCr	19TCr
Total Common Equity	84TCr	86TCr	90TCr	1,01900Cr	1,05800Cr
Minority Interest	922.5Cr	935.3Cr	1.03TCr	1.15TCr	837.4Cr
Total Equity	85TCr	87TCr	91TCr	1,03100Cr	1,06600Cr
Total Liabilities And Equity	99TCr	1,04300Cr	1,09800Cr	1,25700Cr	1,41000Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	89Cr	86Cr	84Cr	82Cr	79Cr
ECS Total Common Shares Outstanding	89Cr	86Cr	84Cr	82Cr	79Cr
Book Value / Share	939.19	996.95	1.06T	1.24T	1.34T
Tangible Book Value	78TCr	81TCr	83TCr	94TCr	97TCr
Tangible Book Value Per Share	875.61	939.11	991.51	1.14T	1.23T
Total Debt	1.53TCr	2.33TCr	2.97TCr	4TCr	5.21TCr
Net Debt	-52TCr	-55TCr	-57TCr	-56TCr	-79TCr
Minority Interest, Total (Incl. Fin. Div)	922.5Cr	935.3Cr	1.03TCr	1.15TCr	837.4Cr
Equity Method Investments, Total	5.89TCr	8.36TCr	5.81TCr	6.37TCr	6.37TCr
Full Time Employees	6.68T	7.47T	8.23T	9.33T	9.83T
Accumulated Allowance for Doubtful Accounts (Supple)	106.5Cr	98Cr	87Cr	86Cr	38Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	14TCr	14TCr	13TCr	20TCr	14TCr
Depreciation & Amortization - CF	846.8Cr	676.7Cr	859.8Cr	1.01TCr	1.14TCr
Depreciation & Amortization, Total	846.8Cr	676.7Cr	859.8Cr	1.01TCr	1.14TCr
(Gain) Loss From Sale Of Asset	294.1Cr	533.7Cr	304Cr	1.34TCr	455.9Cr
(Gain) Loss on Sale of Investments - (CF)	-70Cr	102.5Cr	3.97TCr	-1.88TCr	-592.6Cr
(Income) Loss On Equity Investments - (CF)	100Cr	1.02TCr	351Cr	517.9Cr	169.7Cr
Other Operating Activities, Total	-3.65TCr	-4.02TCr	-5.78TCr	-4.27TCr	-4.51TCr
Change In Accounts Receivable	481.6Cr	-896.8Cr	-451.6Cr	-5.38TCr	862.3Cr
Change In Accounts Payable	-146.6Cr	408.9Cr	95Cr	-304.1Cr	1.93TCr
Change in Other Net Operating Assets	-815.9Cr	1.13TCr	934.1Cr	-544.6Cr	3.69TCr
Cash from Operations	11TCr	13TCr	13TCr	10TCr	17TCr
Capital Expenditure	-158.5Cr	-280.1Cr	-340.7Cr	-363.9Cr	-793.4Cr
Sale of Property, Plant, and Equipment	6.8Cr	12Cr	4.1Cr	14Cr	8.7Cr
Cash Acquisitions	-5.26TCr	-2.9TCr	-2.66TCr	-528.6Cr	-1.35TCr
Divestitures	-	961Cr	13Cr	-	6.7Cr
Sale (Purchase) of Intangible assets	-1.25TCr	-310.1Cr	-230.6Cr	-404.7Cr	-156Cr
Investment in Marketable and Equity Securities, Total	8.91TCr	2.15TCr	-15TCr	2.75TCr	13TCr
Net (Increase) Decrease in Loans Originated / Sold - Investing	-1Cr	-426.7Cr	-613Cr	-510.2Cr	1.9Cr
Other Investing Activities, Total	-427.5Cr	-296.6Cr	-129.6Cr	-206.8Cr	-424.6Cr
Cash from Investing	1.81TCr	-1.09TCr	-19TCr	744.5Cr	10TCr
Short Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Short Term Debt Repaid, Total	-209.4Cr	-	-	-	-
Long-Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-209.4Cr	-	-	-	-
Issuance of Common Stock	410.1Cr	602.3Cr	1.25TCr	444.1Cr	968.5Cr
Repurchase of Common Stock	-1.6TCr	-9.88TCr	-7.9TCr	-5.46TCr	-9.69TCr
Common Dividends Paid	-444.1Cr	-878.5Cr	-857.9Cr	-1.03TCr	-2.44TCr
Common & Preferred Stock Dividends Paid	-444.1Cr	-878.5Cr	-857.9Cr	-1.03TCr	-2.44TCr
Other Financing Activities, Total	-258.5Cr	-427.3Cr	-343.3Cr	-435.9Cr	-709.2Cr
Cash from Financing	-2.11TCr	-11TCr	-7.86TCr	-6.48TCr	-12TCr
Foreign Exchange Rate Adjustments	972.4Cr	3.08TCr	935.6Cr	778Cr	1.15TCr
Net Change in Cash	11TCr	4.41TCr	-13TCr	5.14TCr	17TCr
Supplemental Items
Cash Interest Paid	42Cr	58Cr	140.5Cr	209.6Cr	203.6Cr
Cash Income Tax Paid (Refund)	3.76TCr	3.96TCr	5.42TCr	4.37TCr	4.7TCr
Levered Free Cash Flow	4.41TCr	8.61TCr	6.67TCr	4.57TCr	18TCr
Unlevered Free Cash Flow	4.44TCr	8.65TCr	6.76TCr	4.7TCr	18TCr
Change In Net Working Capital	889.5Cr	-1.74TCr	1.79TCr	4.19TCr	-10TCr
Net Debt Issued / Repaid	-209.4Cr	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.37	6.72	7.72	7.34	5.61
Return on Total Capital	7.37	7.78	9.04	8.62	6.83
Return On Equity %	14.44	11.67	8.01	14.06	8.56
Return on Common Equity	14.86	11.84	8.05	14.08	8.87
Margin Analysis
Gross Profit Margin %	73.72	70.1	67.42	63.06	59.36
SG&A Margin	29.89	30.99	28.06	25.26	27.57
EBITDA Margin %	37.44	32.75	33.26	33.27	27.58
EBITA Margin %	34.35	30.83	31.23	31	25.18
EBIT Margin %	34.35	30.83	31.23	31	25.18
Income From Continuing Operations Margin %	41.2	28.27	16.79	30.53	18.88
Net Income Margin %	41.86	28.37	16.68	30.22	19.38
Net Avail. For Common Margin %	41.86	28.37	16.68	30.22	19.38
Normalized Net Income Margin	31.49	27.24	23.87	26.41	17.68
Levered Free Cash Flow Margin	16.07	24.34	15.75	10.25	37.46
Unlevered Free Cash Flow Margin	16.17	24.44	15.96	10.54	37.73
Asset Turnover
Asset Turnover	0.3	0.35	0.4	0.38	0.36
Fixed Assets Turnover	7.88	8.69	8.57	7.68	6.64
Receivables Turnover (Average Receivables)	14.25	14.73	12.39	7.05	5.43
Short Term Liquidity
Current Ratio	11.13	7.72	7.71	6.99	4.44
Quick Ratio	10.36	7.24	7.1	6.41	4.15
Operating Cash Flow to Current Liabilities	1.99	1.57	1.44	0.94	0.77
Days Sales Outstanding (Average Receivables)	25.61	24.78	29.45	51.92	67.23
Average Days Payable Outstanding	50.66	41.51	41.06	35.51	54.73
Long Term Solvency
Total Debt/Equity	1.81	2.69	3.28	3.88	4.89
Total Debt / Total Capital	1.78	2.62	3.17	3.74	4.66
LT Debt/Equity	1.45	2.22	2.66	3.19	2.94
Long-Term Debt / Total Capital	1.43	2.16	2.57	3.07	2.8
Total Liabilities / Total Assets	14.26	16.81	17.44	18	24.41
EBIT / Interest Expense	227.2	185.48	93.76	65.65	58.15
EBITDA / Interest Expense	247.6	196.99	99.85	70.46	63.69
(EBITDA - Capex) / Interest Expense	243.78	192.23	97.44	68.74	59.84
Total Debt / EBITDA	0.15	0.2	0.21	0.27	0.4
Net Debt / EBITDA	-5.06	-4.74	-4.03	-3.78	-6.02
Total Debt / (EBITDA - Capex)	0.15	0.21	0.22	0.28	0.42
Net Debt / (EBITDA - Capex)	-5.14	-4.85	-4.13	-3.87	-6.41
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-6.33	28.88	19.69	5.4	6.47
Gross Profit, 1 Yr. Growth %	-9.68	22.53	15.12	-1.42	0.23
EBITDA, 1 Yr. Growth %	-21	12.73	21.55	5.45	-11.75
EBITA, 1 Yr. Growth %	-22.4	15.67	21.21	4.63	-13.53
EBIT, 1 Yr. Growth %	-22.4	15.67	21.21	4.63	-13.53
Earnings From Cont. Operations, 1 Yr. Growth %	103.76	-11.56	-28.91	91.63	-34.15
Net Income, 1 Yr. Growth %	104.35	-12.66	-29.63	90.98	-31.74
Normalized Net Income, 1 Yr. Growth %	21.93	11.47	4.88	16.63	-28.74
Diluted EPS Before Extra, 1 Yr. Growth %	104.45	-10.07	-27.66	95.66	-29.16
Accounts Receivable, 1 Yr. Growth %	-16.04	73.2	24.4	134.25	-2.73
Net Property, Plant and Equip., 1 Yr. Growth %	3.54	29.72	14.99	19.88	25.72
Total Assets, 1 Yr. Growth %	14.44	5.7	5.3	14.45	12.21
Tangible Book Value, 1 Yr. Growth %	18.81	3.64	3.23	12.6	3.33
Common Equity, 1 Yr. Growth %	17.86	2.57	4.44	13.7	3.78
Cash From Operations, 1 Yr. Growth %	-23.03	22.88	-1.1	-21.56	70.22
Capital Expenditures, 1 Yr. Growth %	-32.32	76.72	21.64	6.81	118.03
Levered Free Cash Flow, 1 Yr. Growth %	-49.38	95.14	-22.52	-31.44	289.17
Unlevered Free Cash Flow, 1 Yr. Growth %	-49.21	94.83	-21.83	-30.38	281.01
Dividend Per Share, 1 Yr. Growth %	50	33.33	0	125	100
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.09	9.87	24.2	12.32	5.94
Gross Profit, 2 Yr. CAGR %	3.48	5.2	18.77	6.53	-0.6
EBITDA, 2 Yr. CAGR %	-4.55	-5.63	17.05	13.21	-3.53
EBITA, 2 Yr. CAGR %	-5.28	-5.25	18.41	12.62	-4.88
EBIT, 2 Yr. CAGR %	-5.28	-5.25	18.41	12.62	-4.88
Earnings From Cont. Operations, 2 Yr. CAGR %	-0.08	34.24	-20.71	16.72	12.33
Net Income, 2 Yr. CAGR %	-0.34	33.59	-21.6	15.93	14.18
Normalized Net Income, 2 Yr. CAGR %	0.22	16.58	8.12	10.6	-8.83
Diluted EPS Before Extra, 2 Yr. CAGR %	-0.58	35.6	-19.34	18.97	17.73
Accounts Receivable, 2 Yr. CAGR %	-21.66	20.59	46.79	70.71	50.95
Net Property, Plant and Equip., 2 Yr. CAGR %	8.51	15.9	22.13	17.41	22.77
Total Assets, 2 Yr. CAGR %	17.14	9.98	5.5	9.78	13.32
Tangible Book Value, 2 Yr. CAGR %	18.45	10.97	3.43	7.81	7.86
Common Equity, 2 Yr. CAGR %	16.17	9.95	3.5	8.97	8.63
Cash From Operations, 2 Yr. CAGR %	0.4	-2.75	10.24	-11.92	15.56
Capital Expenditures, 2 Yr. CAGR %	5.46	9.36	46.61	13.98	52.6
Levered Free Cash Flow, 2 Yr. CAGR %	-25.73	-0.61	22.96	-27.12	63.35
Unlevered Free Cash Flow, 2 Yr. CAGR %	-25.62	-0.53	23.41	-26.23	62.87
Dividend Per Share, 2 Yr. CAGR %	73.21	41.42	15.47	50	112.13
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	2.65	12.48	13.05	17.59	10.33
Gross Profit, 3 Yr. CAGR %	1.04	9.48	8.41	11.62	4.39
EBITDA, 3 Yr. CAGR %	-3.29	0.89	2.68	13.05	4.19
EBITA, 3 Yr. CAGR %	-4.17	1.24	2.85	13.63	3.12
EBIT, 3 Yr. CAGR %	-4.17	1.24	2.85	13.63	3.12
Earnings From Cont. Operations, 3 Yr. CAGR %	3.16	-4.06	8.61	6.41	-3.56
Net Income, 3 Yr. CAGR %	2.19	-4.63	7.89	5.48	-2.83
Normalized Net Income, 3 Yr. CAGR %	0.8	3.83	12.54	10.89	-4.47
Diluted EPS Before Extra, 3 Yr. CAGR %	1.89	-3.85	9.98	8.38	0.09
Accounts Receivable, 3 Yr. CAGR %	-17.54	2.05	21.85	71.54	41.52
Net Property, Plant and Equip., 3 Yr. CAGR %	12.08	15.16	15.59	21.38	20.12
Total Assets, 3 Yr. CAGR %	14.92	13.19	8.4	8.4	10.58
Tangible Book Value, 3 Yr. CAGR %	15.77	13.29	8.32	6.4	6.3
Common Equity, 3 Yr. CAGR %	14.64	11.45	8.08	6.79	7.21
Cash From Operations, 3 Yr. CAGR %	-3.54	7.39	-2.2	-1.58	9.71
Capital Expenditures, 3 Yr. CAGR %	-1.98	25.27	13.31	31.92	41.49
Levered Free Cash Flow, 3 Yr. CAGR %	-15.62	2.49	-8.53	1.21	27.39
Unlevered Free Cash Flow, 3 Yr. CAGR %	-15.47	2.53	-8.21	1.97	27.52
Dividend Per Share, 3 Yr. CAGR %	-	58.74	25.99	44.22	65.1
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	8.43	8.53	10.78	12.42	10.15
Gross Profit, 5 Yr. CAGR %	8.43	6.82	7.79	8.29	4.71
EBITDA, 5 Yr. CAGR %	6.24	1.25	4.39	5.65	0.15
EBITA, 5 Yr. CAGR %	6.28	1.15	4.29	5.65	-0.31
EBIT, 5 Yr. CAGR %	6.28	1.15	4.29	5.65	-0.31
Earnings From Cont. Operations, 5 Yr. CAGR %	40.68	12.09	-7.14	3.76	10.08
Net Income, 5 Yr. CAGR %	41.67	12.07	-8.09	3.12	10.36
Normalized Net Income, 5 Yr. CAGR %	12.9	13.31	3.67	6.49	3.45
Diluted EPS Before Extra, 5 Yr. CAGR %	41.01	12.39	-7.2	4.7	13.01
Accounts Receivable, 5 Yr. CAGR %	-8.25	-2.89	3.86	25.37	32.75
Net Property, Plant and Equip., 5 Yr. CAGR %	11.68	10.98	16	16.06	18.41
Total Assets, 5 Yr. CAGR %	17.43	13.82	11.06	11.81	10.34
Tangible Book Value, 5 Yr. CAGR %	17.5	13.42	10.67	11.07	8.14
Common Equity, 5 Yr. CAGR %	17.54	13.03	10.05	10.45	8.3
Cash From Operations, 5 Yr. CAGR %	7.64	10.02	1.75	-0.79	4.55
Capital Expenditures, 5 Yr. CAGR %	-8.47	6.41	15.15	20.62	27.64
Levered Free Cash Flow, 5 Yr. CAGR %	-0.28	8.62	-1.9	-10.58	15.35
Unlevered Free Cash Flow, 5 Yr. CAGR %	-0.17	8.69	-1.66	-10.12	15.46
Dividend Per Share, 5 Yr. CAGR %	24.57	-	-	55.18	55.18